Navigation Links
Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms
Date:5/15/2008

Despite daily use of doctor-recommended proton pump inhibitors (PPIs) to control gastroesophageal reflux disease (GERD) symptoms, nearly 40 percent of patients who take them continue to experience breakthrough, which is a return of GERD symptoms, such as acid regurgitation and heartburn. These breakthrough symptoms lead more than half of GERD sufferers to use over-the-counter (OTC) remedies, according to a survey recently conducted by the American Gastroenterological Association (AGA) Institute.

The survey of 1,064 people with GERD found that approximately 56 percent of those who experienced breakthrough used an OTC treatment the majority using an antacid to manage breakthrough symptoms. Further, taking an OTC in addition to a PPI has become routine for these respondents. In fact, more than 70 percent have been using OTC medications for at least one year.

The survey results show that people with GERD are not only using their prescribed PPI, but also are turning to over-the-counter remedies as a stop-gap when they have breakthrough symptoms, said John Inadomi, MD, associate professor of medicine, University of California, San Francisco.

Additional survey findings showed that:

  • More than 40 percent of respondents on a PPI who experience breakthrough symptoms, report those symptoms occur two to four times per week.

  • Respondents report breakthrough symptoms occur throughout the day, sometimes multiple times per day. Sixty-five percent of GERD sufferers experienced breakthrough at night and 28 percent report sleep disruption because of their symptoms.

  • Among patients suffering from breakthrough symptoms, at least 50 percent are not fully satisfied with the specific symptom relief (e.g., acid regurgitation and heartburn) they get from their once-daily PPI.

  • While 98 percent of respondents who experience breakthrough symptoms report taking their PPI as
    '/>"/>

Contact: Molly Rabinovitz
mrabinovitz@wcpglobal.com
312-933-7873
American Gastroenterological Association
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
2. Nearly 30 Percent of Realtors(R) Lack Health Insurance
3. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
4. New Pharmaceutical Sales Force Communication Metrics: Nearly 6 Weeks of Sales Time per Rep Wasted Each Year
5. Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007
6. K-State Researchers Predict That an Outbreak of Foot-And-Mouth Disease Could Cost Kansas Nearly a Billion Dollars
7. Smokers Cost Medicaid System Nearly $10 Billion
8. Research Indicates Nearly 25 Percent of Supplements Are Contaminated With Steroids, Stimulants and Banned Substances
9. Cipla Offers Modest AIDS Drug Price Cut: Not Nearly Enough, says AHF
10. Metabolic syndrome affects nearly 1 in 10 US teens
11. Eleven Florida Nonprofit Organizations to Receive Grants Totaling Nearly $1 Million From The Blue Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...MMR shots found itself in the eye of a storm in th... to autism in some cases.// Recent statistics enab...firmed their faith in the MMR shots, and are well ... from Measles, Mumps and Rubella. The number of M...
...Researchers at the George Institute for Internatio...hat heart disease is the number one killer in rura...a large survey in Andhra Pradesh. The findings of ...rnal of Epidemiology this week. The report said In...
...New study by prescription manager Medco Health sol...ke ADHD medicine end up taking the drugs themselve...000 children and their parents last year. The stu...g ADHD medicine, it is more likely that the other ...
...Tonsillitis, a throat disease common among kids, c...apy, says a new study. // Children aged three-sev...lly caused by viruses, though certain bacteria are...illitis. Michael Pichichero and colleagues at the...
Other Medicine News:Health News:Chronic Diseases Rampant In Rural India 2
(Date:8/19/2008)...AN DIEGO, Aug. 19 /- Vical ...search collaboration with the Karolinska,Institute... the Swedish,Institute for Infectious Disease Cont...te Vical,s Vaxfectin(R) adjuvant with the Biojecto...dical Technologies Inc.,OTCBB: BJCT) for a multiv...
(Date:8/19/2008)...EW HAVEN, Conn., Aug. 19 /-...nounced today that it had,entered into an agreemen...or Hematology Oncology (the "HOVON") to conduct a ...40101M)) with standard remission-induction,therapy...acute myelogenous,leukemia (AML) and high-risk mye...
(Date:8/18/2008)...ORRISTOWN, Pa., Aug. 18 /PRNewswire-USNewswire/ --...virus-infected mosquitoes in,southeastern Pennsylv...nd,its county partners will be stepping up efforts... have -- or are most likely to carry -- the virus....s has been confirmed,this year (a 27-year-old Mont...
(Date:8/18/2008)...OSTON, Aug. 18 /PRNewswire-USNewswire/ -- Boston U...sident of the Center for Human Genetics, Inc.,("CH...of Boston University,announced that CHG will no l...censed to Athena Diagnostics, Inc., These patente...g loss,related to A1555G or Connexin 26 mutations,...
Breaking Medicine Technology:Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery 1375 1Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery 1375 2Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery 1375 3Voices to Unite in Los Angeles for 6 000 Children Orphaned Daily 938 1Voices to Unite in Los Angeles for 6 000 Children Orphaned Daily 938 2Blue dye could hold the key to super processing power 1991 1Blue dye could hold the key to super processing power 1991 2Blue dye could hold the key to super processing power 1991 3Boston Scientific to Participate in BMO Capital Markets Healthcare Conference 7158 1Boston Scientific to Participate in BMO Capital Markets Healthcare Conference 7158 2
...en Londe, M.D. Contributing Editor , ,Celiac ... of the small intestine that is triggered in genet... gluten-containing grains wheat, rye, barley, and ...from the activation of both a T-cell and B-cell im...llous atrophy, and crypt hyperplasia, and is self-...
...th Wegerbauer Contributing Editor ,Since the f...is has revolutionized clinical medicine and patien...e almost universally available, and blood gases we...for critically ill patients," according to a www.b...ntor of the blood gas analysis system., ,Blood...
Other Medicine Technology:Non-Invasive Diagnostic Tests for Celiac Disease 2Non-Invasive Diagnostic Tests for Celiac Disease 3Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 2Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 3Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 4
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 20-200 microliter range.
Pipetman Ultra is a fully adjustable, air-displacement pipette with a patented multifunctional electronic display. It is the latest member of the Pipetman family, sharing many of the same characteris
Research Series 2100 Adjustable-volume Pipette, 20-200 l, single-channel with adjustable-volume setting
... Pipettor for sub-microliter pipetting and beyond....uously adjustable. Features lPLUS, a direct-drive ...hangeable ejector buttons to fit large hands or ti...three different lengths. Air-displacement mechanis...
Medicine Products: